References
- Hou W, Zhang W, Jin R, et al. Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study. Infect Dis (Lond). 2020;52:498–505.
- Bhatraju PK, et al. Covid-19 in critically ill patients in the Seattle Region – case series. N Engl J Med. 2020;382:2012–2022.
- Myers LC, Parodi SM, Escobar GJ, et al. Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California. JAMA. 2020.
- Richardson S, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020.
- NMDOH COVID-19 Public Dashboard. [accessed 2020 May 4]. Available from: https://cvprovider.nmhealth.org/public-dashboard.html
- Guan W, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720.
- Gautret P, Lagier J-C, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020:105949.